DIESSE is an Italian company with an integrated and entirely inhouse production of in vitro diagnostic systems. Its headquarters are in Siena. Since its foundation in 1980, the company has developed, produced and marketed innovative diagnostic systems primarily in the field of immunodiagnostics and automatic measurement of erythrocyte sedimentation rate (ESR). The company has a global presence in over 100 countries, three production sites and a research centre where the design and implementation of tests and new automated diagnostic detection tools meet Italian design and cutting-edge technology, making Diesse synonymous with “Diagnostics Evolution”.
We use our history and our skills in everyday work, integrating advanced research, Made in Italy production and global marketing, for the evolution of our diagnostics systems towards the medicine of future in a sustainable, ethical and transparent way.
In the eighties, when we developed the world’s first system for the fully automated measurement of ESR directly in the test tube, we had one word in mind: evolution. The evolution of research, the evolution of safety for lab technicians, the evolution of In Vitro Diagnostics. When it is driven by a continuous will to innovate, high skills and advanced technological development, evolution is unstoppable.Today this evolution leads us towards the medicine of the future.
Research & Development
In-house biomaterial production
Full in-house production
Entirely Made in Italy
IVD technology innovation
Powered by Italian Design
Full in-house production
DIESSE Diagnostica Senese SpA has been operating for many years in accordance with leading standards for quality management systems, ensuring traceability, transparency, highest quality of its processes, products and services and working on continuous improvement.
The Company is certified in accordance with UNI EN ISO 9001: 2015 and EN ISO 13485: 2016, also in compliance with the MDSAP (Medical Device Single Audit Program) program.
As part of this program, DIESSE Diagnostica Senese SpA has obtained, starting from 2019, the MDSAP certification in accordance with the Regulations of all 5 countries participating to the program: the United States, Canada, Australia, Japan and Brazil.
All products are CE marked in accordance with the European Directive 98/79/EC concerning In Vitro Diagnostic Medical Devices and the relative applicable harmonized standards.
Starting from June 2020 DIESSE Diagnostica Senese S.p.A. has adopted an Organization, Management and Control Model in accordance with Legislative Decree 231/01 (Italian law for crime-risk prevention within business activities) and undertakes to conduct, execute and monitor any activity in accordance with its new Ethical Code
The Company adopted a Corporate Governance Code for the better functioning of the company’s organs. The Company also approved a Code of Ethics.DIESSE is organized according to the management and control model as per articles 2380-bis and following of the Civil Code, with the shareholders' meeting, the Board of Directors and the Board of Auditors. The activity of statutory audit has been entrusted by the shareholders to an auditing firm.DIESSE is managed by a Board of Directors consisting of four members. The Ordinary General Meeting determines, when appointed, the duration of the role which cannot exceed two financial years.The Board of Directors plays a central role within the corporate organization and is entrusted with the powers and the responsibility for strategic and organizational plans, as well as with the evaluation of the existence of the necessary controls to monitor the performance of DIESSE and its subsidiaries. Each member of the Board of Directors is required to act with full knowledge of the facts and autonomously, pursuing the objective of creating value for Shareholders, and is committed to dedicate to the role in DIESSE the time necessary to ensure diligent fulfillment of functions independently from any other positions held, being aware of the responsibilities. To this end, each candidate for the office of Director is required to evaluate in advance, at the time of the acceptance of position, the capacity to perform with due care and effectiveness the assigned tasks, in particular taking into account the overall efforts required by any additional positions held.